Danish pharmaceutical company Lundbeck has entered into a partnership with American AI specialists EVERSANA.
The strategic partnership will serve to advance AI-powered commercialization of Lundbeck's services in the US, the two companies announce in a press release.
Through the deal, Lundbeck plans to broaden its use of EVERSANA's AI Agency platform, “creating a scalable scalable framework for accelerating strategy development, content creation, omnichannel engagement and commercial execution.”
BREAKING